All News

2055 articles, sorted by publication time.

Cancer Research · global

Annamycin Combined with Immunotherapy Extends Survival in Mice with Pancreatic Cancer, with T Cells Emerging as a Key Clue

Moleculin released animal study results showing that Annamycin combined with PD-1 blockade extended survival more than either treatment alone. The findings offer a research direction for pancreatic cancer immunotherapy, but there is no evidence of efficacy in humans, and a planned clinical trial also faces a funding gap.

Cell Therapy · global

AGC’s Yokohama Site Takes On Three Cell Therapy Projects, Supporting Research on Post-Transplant Adenovirus Infection

Institute of Science Tokyo hopes to use third-party virus-specific T cells to tackle refractory adenovirus infection following hematopoietic cell transplantation. AGC Biologics will help develop processes and analytical methods, laying the manufacturing groundwork for the research to move toward clinical use, but this collaboration has not yet provided new evidence of efficacy.